早期炎症性关节炎中宿主防御肽LL37与抗环瓜氨酸肽抗体的关联
本研究在181例未治疗的早期炎症性关节炎患者中检测血清LL-37、25羟维生素D和抗CCP抗体,并分析VDR基因多态性及HLA-DRB1共享表位。多变量模型显示LL37最高四分位水平与抗CCP抗体阳性相关(OR 22,95%CI 4-104)。
要点
- 早期炎症性关节炎患者中LL37最高四分位与抗CCP抗体阳性独立相关。
- 该关联在多变量模型中控制年龄、性别、共享表位、吸烟和维生素D缺乏后仍显著。
- LL37活性可能是连接感染及毒素暴露与抗CCP抗体生成的机制之一。
核心结论
- 循环LL-37水平与早期炎症性关节炎患者抗CCP抗体阳性相关。
研究设计与样本
- 研究纳入181例未治疗的早期炎症性关节炎患者,采用ELISA检测血清LL-37、25羟维生素D和抗CCP抗体,并通过DNA扩增检测VDR单核苷酸多态性及HLA-DRB1共享表位。
主要发现
- 参与者中70%为女性,年龄中位数56岁(45,66),DAS28ESR3var中位数3.7(2.8,4.8),41%抗CCP阳性,68%为类风湿关节炎。
- 血清25羟维生素D水平中位数为20.5 nmol/L(13.9,29.0),提示维生素D缺乏。
- 在多变量模型中控制年龄、性别、共享表位、吸烟和维生素D缺乏后,LL37最高四分位水平与抗CCP抗体阳性相关(OR 22;95%CI 4至104)。
临床怎么用
- 在早期炎症性关节炎评估中,LL-37水平可能有助于识别抗CCP抗体阳性的高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Antibodies to citrullinated peptides (anti-CCP) develop in individuals predisposed to rheumatoid arthritis (RA). Neutrophil extracellular traps are a major source of citrullinated antigens and the immunomodulatory host defence peptide LL-37. Vitamin D regulates LL-37 expression. This study assessed the associations of LL-37 and anti-CCP, vitamin D metabolites and vitamin D receptor (VDR) polymorphisms in early inflammatory arthritis (EIA). METHODS: Serum LL-37, 25-hydroxy-vitamin D (25OHvitD) and anti-CCP were measured by ELISA in treatment naïve EIA (n = 181). VDR single nucleotide polymorphisms (Fok1, Bsm1, Apa1, Taq1, Cdx-2) and HLADRB1 shared epitope (SE) alleles were detected by DNA amplification. Associations were tested in multivariable models. Median (25%, 75%) or percentiles are reported. RESULTS: Participants (70 % female, age 56 [45, 66] years, disease activity score [DAS28ESR3var] 3.7 [2.8, 4.8], 41 % anti-CCP positive, 68 % RA) had low serum 25OHvitD; 20.5 nmol/L (13.9, 29.0). In multivariable models, controlling for age, sex, SE, smoking and vitamin D deficiency, LL37 level (top quartile) associated with anti-CCP seropositivity (OR 22; 95% CI 4 to 104). CONCLUSIONS: Levels of circulating LL-37 are associated with anti-CCP seropositivity. LL37 activity may be one mechanism linking infection and toxin exposure to anti-CCP generation.
引用
- Hitchon CA, Meng X, El Gabalawy HS, et al. Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritis. RMD Open. 2019. PMID: 31245047. doi:10.1136/rmdopen-2018-000874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。